Clinical Trials · NCT03961256
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Mayo Clinic
- Enrollment
- 9
- Start date
- May 2019
- Locations
- 1 site, United States
- Primary endpoint
- Progression From Prediabetes to Diabetes